Concepedia

David N. Standring

DN

51

Publications

4.4K

Citations

32

H-Index

1977

Active since

Affiliations

University of California, San Francisco(Current)

Idera Pharmaceuticals (United States)

Université de Montpellier

Centre National de la Recherche Scientifique

Merck & Co., Inc., Rahway, NJ, USA (United States)

David N. Standring is an author at University of California, San Francisco specializing in medicine, virology, and molecular biology.

Top concepts

Publications per year

1977–2017

51

Publications

51

Insulin-like growth factor II receptor as a multifunctional binding protein

David O. Morgan, Jeffrey C. Edman, David N. Standring et al. · Nature · 1987 · 854 citations

, , +11

Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus

Steven Innaimo, Maria Seifer, Gregory S. Bisacchi et al. · Antimicrobial Agents and Chemotherapy · 1997 · 273 citations · Full text

, , +14

Reduction of aryl azides by thiols: Implications for the use of photoaffinity reagents

James V. Staros, Hagan Bayley, David N. Standring et al. · Biochemical and Biophysical Research Communications · 1978 · 210 citations

, , +7

RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication

Tom H. Hatton, Sen Zhou, David N. Standring · Journal of Virology · 1992 · 207 citations · Full text

, , +16

In Vitro Inhibition of Hepadnavirus Polymerases by the Triphosphates of BMS-200475 and Lobucavir

Maria Seifer, Robert Hamatake, Richard J. Colonno et al. · Antimicrobial Agents and Chemotherapy · 1998 · 200 citations · Full text

, , +21

Rows per page

1–5 of 51